Online ADHD Assessments Show Promise
Clinical relevance: A new study finds that a validated online tool for diagnosing adult ADHD performs nearly as well as clinical interviews. The tool proved highly accurate when diagnosing ADHD but weaker at ruling it out. Researchers found it operated more conservatively than clinicians, often withholding a diagnosis rather than risking overdiagnosis. The study suggests…
Read MoreNoninvasive Brain Stimulation Shows Symptom-Specific Benefits in ADHD
Key point: NIBS may offer targeted therapeutic benefits for patients with ADHD, reducing inattention as well as hyperactivity and impulsivity symptoms.
Read MoreMultinutrient supplements may ease biological stress in children with ADHD
Children with attention-deficit/hyperactivity disorder (ADHD) who took a multinutrient supplement for eight weeks showed reduced levels of reactive oxygen metabolites, according to a new analysis of biological samples collected during a previously published randomized controlled trial. These findings suggest that improved oxidative balance may be one of the ways multinutrient treatment helps reduce behavioral symptoms…
Read MorePsychotropic Medications and Child Health (Commentary)
With the release of Make Our Children Healthy Again: Assessment,1 the federal Make America Healthy Again (MAHA) Commission chaired by the US Secretary of Health and Human Services has elevated poor diet, environmental chemicals, physical inactivity, chronic stress, and medication overprescription as leading threats to the health of our nation’s children. The report could have…
Read MoreHarvard Dean Was Paid $150,000 as an Expert Witness in Tylenol Lawsuits
The Trump administration has cited Dr. Andrea Baccarelli’s expertise to warn against using acetaminophen — the active ingredient in Tylenol — in pregnancy, based on an unproven autism link.
Read MoreTrump urges pregnant women to avoid Tylenol; OB-GYN group disagrees
[Excerpt] The American College of Obstetricians and Gynecologists disagrees with that assessment and reaffirmed the safety and benefits of acetaminophen for pregnant women shortly after Trump’s comments. Dr. Steven Fleischman, president of the ACOG, called Monday’s announcement “irresponsible” and said it “dangerously simplifies the many and complex causes of neurologic challenges in children.” “More than…
Read MoreThe Neurodiversity Paradigm in Eating Disorder Treatment
Key points: Neurodivergent individuals with eating disorders tend to report worse treatment outcomes than neurotypicals. The pathology paradigm views neurodivergence as disordered, failing to incorporate inclusivity into treatment. Through the neurodiversity paradigm, human beings are honored as they seek out mental health care. If eating disorder providers were aligned with the neurodiversity paradigm, radical shifts…
Read MorePsychiatrists describe the “Rumpelstiltskin effect”: The surprising power of simply receiving a diagnosis
Receiving a clinical diagnosis can sometimes feel like a turning point. For many patients, simply being told the name of a condition can bring immediate relief, even before any treatment begins. A new review article published in BJPsych Bulletin explores this phenomenon, proposing that the act of diagnosis itself can be therapeutic. The authors call…
Read MoreEvaluating the Efficacy of CBT Plus Psychopharmacology vs Psychopharmacology Alone in the Treatment of Adult ADHD
Key Takeaways: Adult ADHD affects 2.5% globally, often coexisting with anxiety, depression, and substance use disorders. Pharmacotherapy, especially stimulants, is the primary treatment for adult ADHD, with nonstimulants as alternatives. CBT combined with pharmacotherapy (CBT + M) significantly improves ADHD symptoms at treatment end and 3-month follow-up. The superiority of CBT + M over pharmacotherapy…
Read MorePeople with ADHD traits tend to take bigger financial risks but see lower returns, study finds
People who show signs of attention-deficit hyperactivity disorder tend to take greater financial risks when trading online, but these decisions may come at a cost. A new study published in Scientific Reports suggests that individuals with higher levels of inattention and impulsivity tend to exhibit riskier trading behavior and experience lower investment returns.
Read MoreGestational diabetes poses substantial cognitive dysfunction risks for both mothers and offspring
A new synthesis of global evidence finds that experiencing gestational diabetes during pregnancy is linked with a decline in intellectual function among mothers, and may increase the risk of neurodevelopmental disorders, including autism spectrum disorder and attention-deficit/hyperactivity disorder (ADHD) in children. The ongoing systematic review and meta-analysis of 48 observational studies involving over 9 million…
Read MoreWhat educators should know about Make America Healthy Again misinformation (Opinion)
Teaching students with attention-deficit/hyperactivity disorder requires educators to have a deep understanding of the challenges—and strengths—that the learning difference can bring. But now, U.S. Secretary of Health and Human Services Robert F. Kennedy Jr.’s Make America Healthy Again Commission is adding confusion and mixed messaging to educators’ plates. While the secretary’s views on vaccines have…
Read More